SARC (@sarctrials) 's Twitter Profile
SARC

@sarctrials

SARC is a non-profit dedicated to the development of research for the prevention, treatment, and cure of sarcoma – a cancer of the bone and connective tissues.

ID: 976484792

linkhttp://sarctrials.org calendar_today28-11-2012 16:34:55

600 Tweet

1,1K Followers

344 Following

SARC (@sarctrials) 's Twitter Profile Photo

Launching soon: The enhanced SARC Sarcoma Centers Directory! Helping patients with #sarcoma find sarcoma care across the U.S. and globally. prnewswire.com/news-releases/… 📅 Full reveal at #SARCtrials meeting on May 30 in Chicago! #SarcomaCare #RareCancer

SARC (@sarctrials) 's Twitter Profile Photo

Two weeks until #SARCtrials at #ASCO25! Still time to register—don’t miss the latest in #sarcoma #research and collaboration. Join us Friday, May 30th! sarctrials.org/meetings/sarc-… #ASCO2025

SARC (@sarctrials) 's Twitter Profile Photo

🎙️ New on #SARCTalk: Dr. John Gross of Johns Hopkins Medicine dives into the vital role of #pathology in #sarcoma diagnosis & treatment. From tissue analysis to cutting-edge research, hear how pathologists shape care. Listen now: open.spotify.com/episode/0AVVOj… #SARCTrials

SARC (@sarctrials) 's Twitter Profile Photo

Following the #SARCTrials meeting at #ASCO25, don’t miss the upcoming presentation on #DesmoidTumors. Stick around to learn more about these tumors!

SARC (@sarctrials) 's Twitter Profile Photo

🚨 One week to go! 🚨 Join us for the #SARCTrials meeting at #ASCO25 on Friday, May 30 at Northwestern University. Not too late to register — don’t miss it! 👉 sarctrials.org/meetings/sarc-… #ASCO2025 #sarcoma #Chicago

Herbert Loong, MBBS, FASCO (@herbloong) 's Twitter Profile Photo

Excellent debate at SARC semi-annual meeting pre #ASCO25 on whether neoadjuvant immunotherapy + radiation should now be considered #standardofcare in patients with high grade extremities #STS on the cusp of #SARC32 trial. Always nice to see the #sarcoma community

Excellent debate at <a href="/SARCtrials/">SARC</a> semi-annual meeting pre #ASCO25 on whether neoadjuvant immunotherapy + radiation should now be considered #standardofcare in patients with high grade extremities #STS on the cusp of #SARC32 trial. 

Always nice to see the #sarcoma community
PeerView (@peerview) 's Twitter Profile Photo

Watch Prof. Dr. Patrick Schöffski, MPH & Breelyn A. Wilky, MD discuss the latest #DesmoidTumors updates from #ASCO25 Desmoid Tumor Research Foundation SARC - to participate, visit: bit.ly/DT25-T x.com/i/broadcasts/1…

SARC (@sarctrials) 's Twitter Profile Photo

The SARC Semi-Annual Meeting at #ASCO25 is in the books! Huge thanks to our supporters and all who continue to champion our mission to advance #sarcoma #research. #CancerResearch #SARCTrials #ASCO2025 #clinicaltrials

SARC (@sarctrials) 's Twitter Profile Photo

🎙️ New episode of #SARCTalk is out! Erica Fischer-Cartlidge from @OncologyNursing joins #SARCtrials to discuss the powerful role of nurses in #sarcoma care—plus the future of patient navigation and national collaboration. #nursing #cancercare Listen now: open.spotify.com/episode/1VkQSz…

SARC (@sarctrials) 's Twitter Profile Photo

Missed the #SARCtrials Semi-Annual Meeting? Here's your chance to watch Prof. Dr. Patrick Schöffski (Patrick Schöffski) & Dr. Breelyn A. Wilky (Breelyn Wilky, MD 🎗) discuss all things on tx options for #DesmoidTumor: bit.ly/43YODj8 #sarcoma #oncology Desmoid Tumor Research Foundation PeerView

SARC (@sarctrials) 's Twitter Profile Photo

July is #SarcomaAwarenessMonth 💛 This month, we shine a light on the brave warriors and their families, the researchers working toward cures, and the need for greater awareness and funding. #SarcomaStrong #YellowForSarcoma #sarcomaawareness #sarcoma #SARCTrials

July is #SarcomaAwarenessMonth 💛

This month, we shine a light on the brave warriors and their families, the researchers working toward cures, and the need for greater awareness and funding.

#SarcomaStrong #YellowForSarcoma  #sarcomaawareness #sarcoma #SARCTrials
Stand Up To Cancer (@su2c) 's Twitter Profile Photo

In 2024, the #StandUpToCancer research team led by Dr. David Kirsch announced exciting clinical trial results to help reduce the risk of relapse in soft tissue #sarcoma patients. This breakthrough significantly reduces the risk of cancer relapse at 2 years. This

In 2024, the #StandUpToCancer research team led by Dr. David Kirsch announced exciting clinical trial results to help reduce the risk of relapse in soft tissue #sarcoma patients. This breakthrough significantly reduces the risk of cancer relapse at 2 years. This
SARC (@sarctrials) 's Twitter Profile Photo

🚨 Now Live: The #SARCTrials Sarcoma Directory is your go-to hub for #sarcoma care and support. ✅ Find expert centers ✅ Access patient resources ✅ Connect to #advocacy groups ✅ Search #ClinicalTrials 🔗 Start exploring today: sarctrials.org/patient-resour… #SarcomaAwarenessMonth

🚨 Now Live: The #SARCTrials Sarcoma Directory is your go-to hub for #sarcoma care and support.
✅ Find expert centers
✅ Access patient resources
✅ Connect to #advocacy groups
✅ Search #ClinicalTrials

🔗 Start exploring today: sarctrials.org/patient-resour…

#SarcomaAwarenessMonth